PPM2 COMPREHENSIVE GENOMIC TESTING IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A COST-EFFECTIVENESS ANALYSIS OF PLASMA-BASED CIRCULATING TUMOR DNA (CTDNA) NEXT-GENERATION SEQUENCING (NGS) TO INFORM FIRST-LINE TREATMENT DECISIONS